Treatment for Hepatocellular Carcinoma in South Asia.
作者信息
Acharya Subrat K
机构信息
KIIT University, Bhubaneswar, Odisha, India.
出版信息
J Clin Exp Hepatol. 2021 Nov-Dec;11(6):641-645. doi: 10.1016/j.jceh.2021.09.018. Epub 2021 Sep 24.
Abstract
摘要
相似文献
1
Treatment for Hepatocellular Carcinoma in South Asia.南亚肝细胞癌的治疗
J Clin Exp Hepatol. 2021 Nov-Dec;11(6):641-645. doi: 10.1016/j.jceh.2021.09.018. Epub 2021 Sep 24.
2
Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.射频消融与手术切除治疗肝细胞癌：来自美国国家癌症数据库的当代治疗趋势和结果。
Eur Radiol. 2019 May;29(5):2679-2689. doi: 10.1007/s00330-018-5902-4. Epub 2018 Dec 17.
3
Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.射频消融与再次切除治疗初始根治性切除后复发的≤5cm 肝细胞癌。
Eur Radiol. 2020 Nov;30(11):6357-6368. doi: 10.1007/s00330-020-06990-8. Epub 2020 Jun 11.
4
Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular Carcinoma.乙型肝炎相关肝细胞癌手术切除与射频消融的总生存率比较
Cancers (Basel). 2021 Nov 29;13(23):6009. doi: 10.3390/cancers13236009.
5
Efficacy of re-resection versus radiofrequency ablation for recurrent Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma (HCC) after resection for primary HCC.原发性肝癌切除术后复发性巴塞罗那临床肝癌0/A期肝细胞癌（HCC）再次切除与射频消融的疗效比较
Transl Cancer Res. 2019 Aug;8(4):1035-1045. doi: 10.21037/tcr.2019.06.11.
6
Treatment effect of radiofrequency ablation versus liver transplantation and surgical resection for hepatocellular carcinoma within Milan criteria: a population-based study.射频消融与肝移植和手术切除治疗米兰标准内肝细胞癌的疗效比较：一项基于人群的研究。
Eur Radiol. 2021 Jul;31(7):5379-5389. doi: 10.1007/s00330-020-07551-9. Epub 2021 Jan 6.
7
Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan.射频消融与手术切除治疗 2cm 或更小的单发肝细胞癌：台湾的一项队列研究。
J Formos Med Assoc. 2021 May;120(5):1249-1258. doi: 10.1016/j.jfma.2020.11.010. Epub 2020 Dec 4.
8
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.肝切除术与经皮射频消融治疗早期肝细胞癌的成本效益比较。
J Hepatol. 2013 Aug;59(2):300-7. doi: 10.1016/j.jhep.2013.04.009. Epub 2013 Apr 18.
9
[Clinical observation of surgical resection combined radiofrequency in patients with CNLC Ⅱa~Ⅲa stage multiple hepatocellular carcinoma].
Zhonghua Yi Xue Za Zhi. 2021 Jul 27;101(28):2195-2202. doi: 10.3760/cma.j.cn112137-20210408-00851.
10
Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.射频消融与手术切除治疗早期肝细胞癌：一项澳大利亚多中心研究
Scand J Gastroenterol. 2015 May;50(5):567-76. doi: 10.3109/00365521.2014.953572. Epub 2015 Jan 23.
本文引用的文献
1
Experience With Changing Etiology and Nontransplant Curative Treatment Modalities for Hepatocellular Carcinoma in a Real-Life Setting-A Retrospective Descriptive Analysis.现实环境中肝细胞癌病因变化及非移植性根治性治疗方式的经验——一项回顾性描述性分析
J Clin Exp Hepatol. 2021 Nov-Dec;11(6):682-690. doi: 10.1016/j.jceh.2021.02.002. Epub 2021 Feb 11.
2
New Developments in the Treatment of Hepatocellular Carcinoma: The Concept of Adjuvant and Neoadjuvant Chemotherapy.肝细胞癌治疗的新进展：辅助化疗和新辅助化疗的概念
J Clin Exp Hepatol. 2021 May-Jun;11(3):284-287. doi: 10.1016/j.jceh.2021.04.003. Epub 2021 Apr 27.
3
Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel?晚期肝细胞癌的联合治疗：我们是否看到了隧道尽头的曙光？
Hepatobiliary Surg Nutr. 2021 Apr;10(2):180-192. doi: 10.21037/hbsn-2021-7.
4
Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation.预测米兰标准内完全射频消融后复发性肝细胞癌的结局。
PLoS One. 2020 Nov 10;15(11):e0242113. doi: 10.1371/journal.pone.0242113. eCollection 2020.
5
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.阿替利珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌。
N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745.
6
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.印度肝脏研究全国协会关于印度肝细胞癌预防、诊断和管理的共识2019年更新：普里II建议
J Clin Exp Hepatol. 2020 Jan-Feb;10(1):43-80. doi: 10.1016/j.jceh.2019.09.007. Epub 2019 Sep 23.
7
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.非酒精性脂肪性肝炎是肝移植候选者中肝细胞癌增长最快的病因。
Clin Gastroenterol Hepatol. 2019 Mar;17(4):748-755.e3. doi: 10.1016/j.cgh.2018.05.057. Epub 2018 Jun 14.
8
Surgical Treatment of Hepatocellular Carcinoma.肝细胞癌的外科治疗
Cancer Control. 2017 Jul-Sep;24(3):1073274817729258. doi: 10.1177/1073274817729258.
9
Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma.肝癌切除术后肝失代偿相关因素的层次交互作用。
JAMA Surg. 2016 Sep 1;151(9):846-53. doi: 10.1001/jamasurg.2016.1121.
10
Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.香港肝癌分期系统的建立与肝癌患者治疗分层策略。
Gastroenterology. 2014 Jun;146(7):1691-700.e3. doi: 10.1053/j.gastro.2014.02.032. Epub 2014 Feb 25.
Zotero 插件